TreeWAS – Variant ID: rs41521946

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
C44.3 Skin of other and unspecified parts of face	1.000	0.000	0.000
E10.9 Without complications	0.000	0.000	1.000
K51.9 Ulcerative colitis, unspecified	1.000	0.000	0.000
K90.0 Coeliac disease	0.000	0.000	1.000
C44 Other malignant neoplasms of skin	1.000	0.000	0.000
K51 Ulcerative colitis	1.000	0.000	0.000
J45.9 Asthma, unspecified	0.000	0.000	1.000
C44.7 Skin of lower limb, including hip	0.999	0.001	0.000
E10 Insulin-dependent diabetes mellitus	0.000	0.001	0.999
K50-K52 Noninfective enteritis and colitis	0.999	0.001	0.000
K50 Crohn's disease [regional enteritis]	0.999	0.001	0.000
K50.1 Crohn's disease of large intestine	0.999	0.001	0.000
Z93.2 Ileostomy status	0.997	0.003	0.000
C44.4 Skin of scalp and neck	0.996	0.004	0.000
K51.4 Pseudopolyposis of colon	0.989	0.011	0.000
C82.9 Follicular non-Hodgkin's lymphoma, unspecified	0.988	0.012	0.000
E10.1 With ketoacidosis	0.000	0.013	0.987
D86.9 Sarcoidosis, unspecified	0.000	0.013	0.987
D86 Sarcoidosis	0.000	0.013	0.987
E10.3 With ophthalmic complications	0.000	0.016	0.984
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.983	0.017	0.000
C44.2 Skin of ear and external auricular canal	0.979	0.021	0.000
D86.0 Sarcoidosis of lung	0.000	0.025	0.975
C44.5 Skin of trunk	0.972	0.028	0.000
C44.6 Skin of upper limb, including shoulder	0.970	0.030	0.000
K51.8 Other ulcerative colitis	0.968	0.032	0.000
C44.0 Skin of lip	0.964	0.036	0.000
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.956	0.044	0.000
K51.2 Ulcerative (chronic) proctitis	0.950	0.050	0.000
C83 Diffuse non-Hodgkin's lymphoma	0.938	0.062	0.000
K50.9 Crohn's disease, unspecified	0.933	0.067	0.000
C83.3 Large cell (diffuse)	0.931	0.069	0.000
C85 Other and unspecified types of non-Hodgkin's lymphoma	0.927	0.073	0.000
C82.0 Small cleaved cell, follicular	0.905	0.095	0.000
C85.9 Non-Hodgkin's lymphoma, unspecified type	0.905	0.095	0.000
D86.8 Sarcoidosis of other and combined sites	0.000	0.098	0.902
D86.1 Sarcoidosis of lymph nodes	0.000	0.110	0.890
E10.8 With unspecified complications	0.000	0.159	0.841
C44.1 Skin of eyelid, including canthus	0.839	0.161	0.000
K51.5 Mucosal proctocolitis	0.838	0.162	0.000
C82.7 Other types of follicular non-Hodgkin's lymphoma	0.825	0.175	0.000
D80-D89 Certain disorders involving the immune mechanism	0.000	0.178	0.822
D51 Vitamin B12 deficiency anaemia	0.000	0.183	0.817
D50-D53 Nutritional anaemias	0.000	0.185	0.815
D51.0 Vitamin B12 deficiency anaemia due to intrinsic factor deficiency	0.000	0.188	0.812
C82.3 Follicular lymphoma grade IIIa	0.793	0.207	0.000
Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism	0.000	0.209	0.791
D50 Iron deficiency anaemia	0.000	0.214	0.786
C44.9 Malignant neoplasm of skin, unspecified	0.783	0.217	0.000
D50.9 Iron deficiency anaemia, unspecified	0.000	0.219	0.781
K52 Other non-infective gastro-enteritis and colitis	0.781	0.219	0.000
K90 Intestinal malabsorption	0.000	0.225	0.775
E10.4 With neurological complications	0.000	0.232	0.768
C85.1 B-cell lymphoma, unspecified	0.758	0.242	0.000
E10.6 With other specified complications	0.000	0.247	0.752
D51.9 Vitamin B12 deficiency anaemia, unspecified	0.000	0.249	0.751
K51.3 Ulcerative (chronic) rectosigmoiditis	0.748	0.252	0.000
E10.0 With coma	0.000	0.254	0.746
K50.8 Other Crohn's disease	0.745	0.255	0.000
C83.1 Small cleaved cell (diffuse)	0.742	0.258	0.000
M06.9 Rheumatoid arthritis, unspecified	0.722	0.278	0.000
C44.8 Overlapping lesion of skin	0.717	0.283	0.000
E10.7 With multiple complications	0.000	0.283	0.716
M06 Other rheumatoid arthritis	0.715	0.285	0.000
K51.0 Ulcerative (chronic) enterocolitis	0.714	0.286	0.000
E10.2 With renal complications	0.000	0.289	0.711
M06.0 Seronegative rheumatoid arthritis	0.711	0.289	0.000
C82.2 Large cell, follicular	0.709	0.290	0.000
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified	0.708	0.292	0.000
D86.3 Sarcoidosis of skin	0.000	0.292	0.707
D86.2 Sarcoidosis of lung with sarcoidosis of lymph nodes	0.000	0.292	0.707
C82.6 Cutaneous follicle centre lymphoma	0.705	0.295	0.000
C82.5 Diffuse follicle centre lymphoma	0.705	0.295	0.000
C82.4 Follicular lymphoma grade IIIb	0.705	0.295	0.000
C84 Peripheral and cutaneous T-cell lymphomas	0.705	0.295	0.000
M06.00 Seronegative rheumatoid arthritis (Multiple sites)	0.702	0.298	0.000
M06.99 Rheumatoid arthritis, unspecified (Site unspecified)	0.702	0.298	0.000
M06.90 Rheumatoid arthritis, unspecified (Multiple sites)	0.700	0.300	0.000
K90.4 Malabsorption due to intolerance, not elsewhere classified	0.000	0.311	0.689
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.685	0.315	0.000
C94 Other leukaemias of specified cell type	0.685	0.315	0.000
C93 Monocytic leukaemia	0.685	0.315	0.000
C86 Other specified types of T/NK-cell lymphoma	0.685	0.315	0.000
C81 Hodgkin's disease	0.685	0.315	0.000
K52.8 Other specified non-infective gastro-enteritis and colitis	0.678	0.322	0.000
C95 Leukaemia of unspecified cell type	0.676	0.324	0.000
C83.6 Undifferentiated (diffuse)	0.672	0.327	0.000
C83.5 Lymphoblastic (diffuse)	0.672	0.327	0.000
C83.4 Immunoblastic (diffuse)	0.672	0.327	0.000
C83.2 Mixed small and large cell (diffuse)	0.672	0.327	0.000
C82.1 Mixed small cleaved and large cell, follicular	0.665	0.335	0.000
C85.2 Mediastinal (thymic) large B-cell lymphoma	0.664	0.335	0.000
C85.0 Lymphosarcoma	0.664	0.335	0.000
K52.1 Toxic gastro-enteritis and colitis	0.660	0.340	0.000
D52 Folate deficiency anaemia	0.000	0.352	0.648
M06.96 Rheumatoid arthritis, unspecified (Lower leg)	0.648	0.352	0.000
C83.7 Burkitt's tumour	0.646	0.353	0.000
K51.1 Ulcerative (chronic) ileocolitis	0.641	0.359	0.000
E10.5 With peripheral circulatory complications	0.000	0.366	0.634
E10-E14 Diabetes mellitus	0.000	0.366	0.634
K52.3 Indeterminate colitis	0.632	0.368	0.000
K90.9 Intestinal malabsorption, unspecified	0.000	0.371	0.629
C90 Multiple myeloma and malignant plasma cell neoplasms	0.627	0.373	0.000
C43-C44 Melanoma and other malignant neoplasms of skin	0.623	0.377	0.000
C88 Malignant immunoproliferative diseases	0.615	0.385	0.000
M06.09 Seronegative rheumatoid arthritis (Site unspecified)	0.608	0.392	0.000
M06.98 Rheumatoid arthritis, unspecified (Other)	0.606	0.394	0.000
C83.8 Other types of diffuse non-Hodgkin's lymphoma	0.592	0.408	0.000
D82 Immunodeficiency associated with other major defects	0.000	0.411	0.589
D81 Combined immunodeficiencies	0.000	0.411	0.589
K90.8 Other intestinal malabsorption	0.000	0.414	0.586
D51.8 Other vitamin B12 deficiency anaemias	0.000	0.414	0.585
D51.3 Other dietary vitamin B12 deficiency anaemia	0.000	0.414	0.585
D51.2 Transcobalamin II deficiency	0.000	0.414	0.585
D51.1 Vitamin B12 deficiency anaemia due to selective vitamin B12 malabsorption with proteinuria	0.000	0.414	0.585
M06.95 Rheumatoid arthritis, unspecified (Pelvic region and thigh)	0.578	0.422	0.000
K52.2 Allergic and dietetic gastro-enteritis and colitis	0.571	0.429	0.000
M06.97 Rheumatoid arthritis, unspecified (Ankle and foot)	0.565	0.435	0.000
C81.1 Nodular sclerosis	0.565	0.435	0.000
D53 Other nutritional anaemias	0.000	0.435	0.565
D50.1 Sideropenic dysphagia	0.000	0.436	0.563
E16.2 Hypoglycaemia, unspecified	0.000	0.441	0.559
K90.3 Pancreatic steatorrhoea	0.000	0.444	0.556
K90.2 Blind loop syndrome, not elsewhere classified	0.000	0.444	0.556
K90.1 Tropical sprue	0.000	0.444	0.556
E16 Other disorders of pancreatic internal secretion	0.000	0.446	0.554
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion	0.000	0.453	0.547
M05-M14 Inflammatory polyarthropathies	0.547	0.453	0.000
C85.7 Other specified types of non-Hodgkin's lymphoma	0.544	0.456	0.000
Chapter IV Endocrine, nutritional and metabolic diseases	0.000	0.457	0.543
D83 Common variable immunodeficiency	0.000	0.459	0.541
M06.06 Seronegative rheumatoid arthritis (Lower leg)	0.536	0.464	0.000
M06.93 Rheumatoid arthritis, unspecified (Forearm)	0.530	0.470	0.000
C84.4 Peripheral T-cell lymphoma	0.529	0.471	0.000
D52.9 Folate deficiency anaemia, unspecified	0.000	0.471	0.528
C95.0 Acute leukaemia of unspecified cell type	0.526	0.474	0.000
D55-D59 Haemolytic anaemias	0.000	0.479	0.521
C84.0 Mycosis fungoides	0.519	0.480	0.000
D80 Immunodeficiency with predominantly antibody defects	0.000	0.482	0.518
C81.0 Lymphocytic predominance	0.517	0.483	0.000
M06.8 Other specified rheumatoid arthritis	0.513	0.487	0.000
M06.2 Rheumatoid bursitis	0.513	0.487	0.000
M06.1 Adult-onset Still's disease	0.513	0.487	0.000
M06.08 Seronegative rheumatoid arthritis (Other)	0.510	0.490	0.000
M06.07 Seronegative rheumatoid arthritis (Ankle and foot)	0.510	0.490	0.000
M06.05 Seronegative rheumatoid arthritis (Pelvic region and thigh)	0.510	0.490	0.000
M06.04 Seronegative rheumatoid arthritis (Hand)	0.510	0.490	0.000
M06.03 Seronegative rheumatoid arthritis (Forearm)	0.510	0.490	0.000
M06.02 Seronegative rheumatoid arthritis (Upper arm)	0.510	0.490	0.000
M06.01 Seronegative rheumatoid arthritis (Shoulder region)	0.510	0.490	0.000
C84.9 Mature T/NK-cell lymphoma, unspecified	0.505	0.495	0.000
C84.8 Cutaneous T-cell lymphoma, unspecified	0.505	0.495	0.000
C84.7 Anaplastic large cell lymphoma, ALK-negative	0.505	0.495	0.000
C84.6 Anaplastic large cell lymphoma, ALK-positive	0.505	0.495	0.000
C84.3 Lymphoepithelioid lymphoma	0.505	0.495	0.000
C84.2 T-zone lymphoma	0.505	0.495	0.000
C84.1 Sezary's diease	0.505	0.495	0.000
C81.2 Mixed cellularity	0.503	0.497	0.000
M05 Seropositive rheumatoid arthritis	0.503	0.497	0.000
M06.4 Inflammatory polyarthropathy	0.495	0.505	0.000
C86.6 Primary cutaneous CD30-positive T-cell proliferations	0.491	0.508	0.000
C86.5 Angioimmunoblastic T-cell lymphoma	0.491	0.508	0.000
C86.4 Blastic NK-cell lymphoma	0.491	0.508	0.000
C86.3 Subcutaneous panniculitis-like T-cell lymphoma	0.491	0.508	0.000
C86.2 Enteropathy-type (intestinal) T-cell lymphoma	0.491	0.508	0.000
C86.1 Hepatosplenic T-cell lymphoma	0.491	0.508	0.000
C86.0 Extranodal NK/T-cell lymphoma, nasal type	0.491	0.508	0.000
C93.9 Monocytic leukaemia, unspecified	0.491	0.508	0.000
C93.7 Other monocytic leukaemia	0.491	0.508	0.000
C93.3 Juvenile myelomonocytic leukaemia	0.491	0.508	0.000
C93.2 Subacute monocytic leukaemia	0.491	0.508	0.000
C93.1 Chronic monocytic leukaemia	0.491	0.508	0.000
C93.0 Acute monocytic leukaemia	0.491	0.508	0.000
C94.7 Other specified leukaemias	0.491	0.508	0.000
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified	0.491	0.508	0.000
C94.5 Acute myelofibrosis	0.491	0.508	0.000
C94.4 Acute panmyelosis	0.491	0.508	0.000
C94.3 Mast cell leukaemia	0.491	0.508	0.000
C94.2 Acute megakaryoblastic leukaemia	0.491	0.508	0.000
C94.1 Chronic erythraemia	0.491	0.508	0.000
C94.0 Acute erythraemia and erythroleukaemia	0.491	0.508	0.000
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified	0.491	0.508	0.000
C96.8 Histiocytic sarcoma	0.491	0.508	0.000
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.491	0.508	0.000
C96.6 Unifocal Langerhans-cell histiocytosis	0.491	0.508	0.000
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis	0.491	0.508	0.000
C96.4 Sarcoma of dendritic cells (accessory cells)	0.491	0.508	0.000
C96.3 True histiocytic lymphoma	0.491	0.508	0.000
C96.2 Malignant mast cell tumour	0.491	0.508	0.000
C96.1 Malignant histiocytosis	0.491	0.508	0.000
C96.0 Letterer-Siwe disease	0.491	0.508	0.000
E20-E35 Disorders of other endocrine glands	0.000	0.509	0.491
M06.3 Rheumatoid nodule	0.491	0.509	0.000
C81.7 Other Hodgkin's disease	0.491	0.509	0.000
C81.4 Lymphocyte-rich classical Hodgkin lymphoma	0.491	0.509	0.000
C81.3 Lymphocytic depletion	0.491	0.509	0.000
D84 Other immunodeficiencies	0.000	0.511	0.488
M07 Psoriatic and enteropathic arthropathies	0.486	0.514	0.000
C95.7 Other leukaemia of unspecified cell type	0.485	0.515	0.000
C95.2 Subacute leukaemia of unspecified cell type	0.485	0.515	0.000
C95.1 Chronic leukaemia of unspecified cell type	0.485	0.515	0.000
E27 Other disorders of adrenal gland	0.000	0.515	0.485
C84.5 Other and unspecified T-cell lymphomas	0.484	0.515	0.000
E27.1 Primary adrenocortical insufficiency	0.000	0.516	0.484
M05.9 Seropositive rheumatoid arthritis, unspecified	0.471	0.529	0.000
E13 Other specified diabetes mellitus	0.000	0.529	0.471
D52.8 Other folate deficiency anaemias	0.000	0.535	0.465
D52.1 Drug-induced folate deficiency anaemia	0.000	0.535	0.465
D52.0 Dietary folate deficiency anaemia	0.000	0.535	0.465
M06.91 Rheumatoid arthritis, unspecified (Shoulder region)	0.459	0.541	0.000
C91 Lymphoid leukaemia	0.454	0.545	0.001
E12 Malnutrition-related diabetes mellitus	0.000	0.546	0.454
C90.0 Multiple myeloma	0.451	0.549	0.000
C90.3 Solitary plasmacytoma	0.449	0.551	0.000
C90.1 Plasma cell leukaemia	0.449	0.551	0.000
Chapter II Neoplasms	0.447	0.552	0.000
E16.1 Other hypoglycaemia	0.000	0.553	0.447
C73-C75 Malignant neoplasms of thyroid and other endocrine glands	0.444	0.556	0.000
D50.0 Iron deficiency anaemia secondary to blood loss (chronic)	0.000	0.557	0.443
M07.3 Other psoriatic arthropathies	0.443	0.557	0.000
C88.9 Malignant immunoproliferative disease, unspecified	0.441	0.559	0.000
C88.7 Other malignant immunoproliferative diseases	0.441	0.559	0.000
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]	0.441	0.559	0.000
C88.3 Immunoproliferative small intestinal disease	0.441	0.559	0.000
C88.2 Gamma heavy chain disease	0.441	0.559	0.000
C88.1 Alpha heavy chain disease	0.441	0.559	0.000
C73 Malignant neoplasm of thyroid gland	0.441	0.559	0.000
D89 Other disorders involving the immune mechanism, not elsewhere classified	0.000	0.563	0.437
E16.0 Drug-induced hypoglycaemia without coma	0.000	0.566	0.434
M06.92 Rheumatoid arthritis, unspecified (Upper arm)	0.429	0.571	0.000
M45.X9 Ankylosing spondylitis (Site unspecified)	0.428	0.572	0.000
C92 Myeloid leukaemia	0.427	0.573	0.000
K52.0 Gastro-enteritis and colitis due to radiation	0.427	0.573	0.000
D59 Acquired haemolytic anaemia	0.000	0.574	0.426
E22 Hyperfunction of pituitary gland	0.000	0.576	0.424
D81.9 Combined immunodeficiency, unspecified	0.000	0.577	0.423
D81.8 Other combined immunodeficiencies	0.000	0.577	0.423
D81.7 Major histocompatibility complex class II deficiency	0.000	0.577	0.423
D81.6 Major histocompatibility complex class I deficiency	0.000	0.577	0.423
D81.5 Purine nucleoside phosphorylase [PNP] deficiency	0.000	0.577	0.423
D81.4 Nezelof's syndrome	0.000	0.577	0.423
D81.3 Adenosine deaminase [ADA] deficiency	0.000	0.577	0.423
D81.2 Severe combined immunodeficiency [SCID] with low or normal B-cell numbers	0.000	0.577	0.423
D81.1 Severe combined immunodeficiency [SCID] with low T- and B-cell numbers	0.000	0.577	0.423
D81.0 Severe combined immunodeficiency [SCID] with reticular dysgenesis	0.000	0.577	0.423
D82.9 Immunodeficiency associated with major defect, unspecified	0.000	0.577	0.423
D82.8 Immunodeficiency associated with other specified major defects	0.000	0.577	0.423
D82.4 Hyperimmunoglobulin E [IgE] syndrome	0.000	0.577	0.423
D82.3 Immunodeficiency following hereditary defective response to Epstein-Barr virus	0.000	0.577	0.423
D82.2 Immunodeficiency with short-limbed stature	0.000	0.577	0.423
D82.1 Di George's syndrome	0.000	0.577	0.423
D82.0 Wiskott-Aldrich syndrome	0.000	0.577	0.423
C95.9 Leukaemia, unspecified	0.421	0.579	0.000
C83.0 Small cell (diffuse)	0.409	0.591	0.001
E14 Unspecified diabetes mellitus	0.000	0.592	0.408
D53.8 Other specified nutritional anaemias	0.000	0.595	0.405
D53.2 Scorbutic anaemia	0.000	0.595	0.405
D53.1 Other megaloblastic anaemias, not elsewhere classified	0.000	0.595	0.405
D53.0 Protein deficiency anaemia	0.000	0.595	0.405
M45 Ankylosing spondylitis	0.402	0.598	0.000
M05.90 Seropositive rheumatoid arthritis, unspecified (Multiple sites)	0.400	0.600	0.000
E16.9 Disorder of pancreatic internal secretion, unspecified	0.000	0.602	0.397
E16.8 Other specified disorders of pancreatic internal secretion	0.000	0.602	0.397
E16.4 Abnormal secretion of gastrin	0.000	0.602	0.397
E16.3 Increased secretion of glucagon	0.000	0.602	0.397
E15 Nondiabetic hypoglycaemic coma	0.000	0.608	0.392
M12 Other specific arthropathies	0.392	0.608	0.000
M09 Juvenile arthritis in diseases classified elsewhere	0.392	0.608	0.000
M08 Juvenile arthritis	0.392	0.608	0.000
C91.5 Adult T-cell leukaemia	0.389	0.610	0.001
M05.99 Seropositive rheumatoid arthritis, unspecified (Site unspecified)	0.389	0.611	0.000
C90.2 Plasmacytoma, extramedullary	0.388	0.612	0.000
D83.8 Other common variable immunodeficiencies	0.000	0.612	0.388
D83.2 Common variable immunodeficiency with autoantibodies to B- or T-cells	0.000	0.612	0.388
D83.1 Common variable immunodeficiency with predominant immunoregulatory T-cell disorders	0.000	0.612	0.388
D83.0 Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function	0.000	0.612	0.388
M14 Arthropathies in other diseases classified elsewhere	0.386	0.613	0.000
D53.9 Nutritional anaemia, unspecified	0.000	0.615	0.385
E24 Cushing's syndrome	0.000	0.617	0.383
M11 Other crystal arthropathies	0.382	0.617	0.000
E27.4 Other and unspecified adrenocortical insufficiency	0.000	0.619	0.381
E21 Hyperparathyroidism and other disorders of parathyroid gland	0.000	0.619	0.381
M07.39 Other psoriatic arthropathies (Site unspecified)	0.379	0.621	0.000
E27.2 Addisonian crisis	0.000	0.622	0.378
C00-C14 Malignant neoplasms of lip, oral cavity and pharynx	0.378	0.622	0.000
M05.97 Seropositive rheumatoid arthritis, unspecified (Ankle and foot)	0.378	0.622	0.000
M05.96 Seropositive rheumatoid arthritis, unspecified (Lower leg)	0.374	0.626	0.000
D57 Sickle-cell disorders	0.000	0.626	0.374
D55 Anaemia due to enzyme disorders	0.000	0.626	0.374
M06.40 Inflammatory polyarthropathy (Multiple sites)	0.373	0.626	0.000
E22.2 Syndrome of inappropriate secretion of antidiuretic hormone	0.000	0.627	0.373
D80.9 Immunodeficiency with predominantly antibody defects, unspecified	0.000	0.628	0.371
D80.8 Other immunodeficiencies with predominantly antibody defects	0.000	0.628	0.371
D80.7 Transient hypogammaglobulinaemia of infancy	0.000	0.628	0.371
D80.6 Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinaemia	0.000	0.628	0.371
D80.5 Immunodeficiency with increased immunoglobulin M [IgM]	0.000	0.628	0.371
D80.4 Selective deficiency of immunoglobulin M [IgM]	0.000	0.628	0.371
D80.3 Selective deficiency of immunoglobulin G [IgG] subclasses	0.000	0.628	0.371
D80.0 Hereditary hypogammaglobulinaemia	0.000	0.628	0.371
C88.0 Waldenstrom's macroglobulinaemia	0.371	0.629	0.000
C91.9 Lymphoid leukaemia, unspecified	0.368	0.632	0.001
M06.19 Adult-onset Still's disease (Site unspecified)	0.368	0.632	0.000
M06.18 Adult-onset Still's disease (Other)	0.368	0.632	0.000
M06.17 Adult-onset Still's disease (Ankle and foot)	0.368	0.632	0.000
M06.16 Adult-onset Still's disease (Lower leg)	0.368	0.632	0.000
M06.15 Adult-onset Still's disease (Pelvic region and thigh)	0.368	0.632	0.000
M06.14 Adult-onset Still's disease (Hand)	0.368	0.632	0.000
M06.13 Adult-onset Still's disease (Forearm)	0.368	0.632	0.000
M06.12 Adult-onset Still's disease (Upper arm)	0.368	0.632	0.000
M06.11 Adult-onset Still's disease (Shoulder region)	0.368	0.632	0.000
M06.10 Adult-onset Still's disease (Multiple sites)	0.368	0.632	0.000
M06.29 Rheumatoid bursitis (Site unspecified)	0.368	0.632	0.000
M06.28 Rheumatoid bursitis (Other)	0.368	0.632	0.000
M06.27 Rheumatoid bursitis (Ankle and foot)	0.368	0.632	0.000
M06.26 Rheumatoid bursitis (Lower leg)	0.368	0.632	0.000
M06.25 Rheumatoid bursitis (Pelvic region and thigh)	0.368	0.632	0.000
M06.24 Rheumatoid bursitis (Hand)	0.368	0.632	0.000
M06.23 Rheumatoid bursitis (Forearm)	0.368	0.632	0.000
M06.22 Rheumatoid bursitis (Upper arm)	0.368	0.632	0.000
M06.21 Rheumatoid bursitis (Shoulder region)	0.368	0.632	0.000
M06.20 Rheumatoid bursitis (Multiple sites)	0.368	0.632	0.000
M06.89 Other specified rheumatoid arthritis (Site unspecified)	0.368	0.632	0.000
M06.88 Other specified rheumatoid arthritis (Other)	0.368	0.632	0.000
M06.87 Other specified rheumatoid arthritis (Ankle and foot)	0.368	0.632	0.000
M06.86 Other specified rheumatoid arthritis (Lower leg)	0.368	0.632	0.000
M06.85 Other specified rheumatoid arthritis (Pelvic region and thigh)	0.368	0.632	0.000
M06.84 Other specified rheumatoid arthritis (Hand)	0.368	0.632	0.000
M06.83 Other specified rheumatoid arthritis (Forearm)	0.368	0.632	0.000
M06.82 Other specified rheumatoid arthritis (Upper arm)	0.368	0.632	0.000
M06.81 Other specified rheumatoid arthritis (Shoulder region)	0.368	0.632	0.000
M06.80 Other specified rheumatoid arthritis (Multiple sites)	0.368	0.632	0.000
M07.36 Other psoriatic arthropathies (Lower leg)	0.363	0.637	0.000
M05.8 Other seropositive rheumatoid arthritis	0.361	0.639	0.000
M05.3 Rheumatoid arthritis with involvement of other organs and systems	0.361	0.639	0.000
M05.2 Rheumatoid vasculitis	0.361	0.639	0.000
M05.1 Rheumatoid lung disease	0.361	0.639	0.000
M05.0 Felty's syndrome	0.361	0.639	0.000
M06.37 Rheumatoid nodule (Ankle and foot)	0.360	0.640	0.000
M45.X2 Ankylosing spondylitis (Cervical region)	0.359	0.641	0.000
D59.1 Other autoimmune haemolytic anaemias	0.000	0.641	0.359
E20 Hypoparathyroidism	0.000	0.643	0.356
D80.1 Nonfamilial hypogammaglobulinaemia	0.000	0.644	0.355
M06.48 Inflammatory polyarthropathy (Other)	0.355	0.645	0.000
M06.47 Inflammatory polyarthropathy (Ankle and foot)	0.355	0.645	0.000
M06.46 Inflammatory polyarthropathy (Lower leg)	0.355	0.645	0.000
M06.45 Inflammatory polyarthropathy (Pelvic region and thigh)	0.355	0.645	0.000
M06.44 Inflammatory polyarthropathy (Hand)	0.355	0.645	0.000
M06.43 Inflammatory polyarthropathy (Forearm)	0.355	0.645	0.000
M06.42 Inflammatory polyarthropathy (Upper arm)	0.355	0.645	0.000
M06.41 Inflammatory polyarthropathy (Shoulder region)	0.355	0.645	0.000
E13.9 Without complications	0.000	0.646	0.354
C43 Malignant melanoma of skin	0.353	0.647	0.000
E35 Disorders of endocrine glands in diseases classified elsewhere	0.000	0.647	0.352
E32 Diseases of thymus	0.000	0.647	0.352
E31 Polyglandular dysfunction	0.000	0.647	0.352
E30 Disorders of puberty, not elsewhere classified	0.000	0.647	0.352
E25 Adrenogenital disorders	0.000	0.647	0.352
M06.39 Rheumatoid nodule (Site unspecified)	0.352	0.648	0.000
M06.38 Rheumatoid nodule (Other)	0.352	0.648	0.000
M06.36 Rheumatoid nodule (Lower leg)	0.352	0.648	0.000
M06.35 Rheumatoid nodule (Pelvic region and thigh)	0.352	0.648	0.000
M06.33 Rheumatoid nodule (Forearm)	0.352	0.648	0.000
M06.31 Rheumatoid nodule (Shoulder region)	0.352	0.648	0.000
M06.30 Rheumatoid nodule (Multiple sites)	0.352	0.648	0.000
D84.8 Other specified immunodeficiencies	0.000	0.649	0.350
D84.1 Defects in the complement system	0.000	0.649	0.350
D84.0 Lymphocyte function antigen-1 [LFA-1] defect	0.000	0.649	0.350
M07.6 Other enteropathic arthropathies	0.348	0.651	0.000
M07.5 Arthropathy in ulcerative colitis	0.348	0.651	0.000
M07.4 Arthropathy in Crohn's disease [regional enteritis]	0.348	0.651	0.000
M07.2 Psoriatic spondylitis	0.348	0.651	0.000
M07.1 Arthritis mutilans	0.348	0.651	0.000
M07.0 Distal interphalangeal psoriatic arthropathy	0.348	0.651	0.000
E27.3 Drug-induced adrenocortical insufficiency	0.000	0.652	0.348
E27.5 Adrenomedullary hyperfunction	0.000	0.652	0.348
E27.0 Other adrenocortical overactivity	0.000	0.652	0.348
C74 Malignant neoplasm of adrenal gland	0.347	0.653	0.000
C02 Malignant neoplasm of other and unspecified parts of tongue	0.346	0.654	0.000
M07.37 Other psoriatic arthropathies (Ankle and foot)	0.346	0.654	0.000
M06.34 Rheumatoid nodule (Hand)	0.344	0.655	0.000
E40-E46 Malnutrition	0.000	0.660	0.340
D83.9 Common variable immunodeficiency, unspecified	0.000	0.660	0.339
M05.98 Seropositive rheumatoid arthritis, unspecified (Other)	0.338	0.662	0.000
M05.95 Seropositive rheumatoid arthritis, unspecified (Pelvic region and thigh)	0.338	0.662	0.000
M05.94 Seropositive rheumatoid arthritis, unspecified (Hand)	0.338	0.662	0.000
M05.93 Seropositive rheumatoid arthritis, unspecified (Forearm)	0.338	0.662	0.000
M05.92 Seropositive rheumatoid arthritis, unspecified (Upper arm)	0.338	0.662	0.000
M05.91 Seropositive rheumatoid arthritis, unspecified (Shoulder region)	0.338	0.662	0.000
E13.8 With unspecified complications	0.000	0.662	0.337
E13.7 With multiple complications	0.000	0.662	0.337
E13.6 With other specified complications	0.000	0.662	0.337
E13.5 With peripheral circulatory complications	0.000	0.662	0.337
E13.4 With neurological complications	0.000	0.662	0.337
E13.3 With ophthalmic complications	0.000	0.662	0.337
E13.2 With renal complications	0.000	0.662	0.337
E13.1 With ketoacidosis	0.000	0.662	0.337
E13.0 With coma	0.000	0.662	0.337
M45-M49 Spondylopathies	0.333	0.667	0.000
M06.32 Rheumatoid nodule (Upper arm)	0.330	0.670	0.000
D65-D69 Coagulation defects, purpura and other haemorrhagic conditions	0.000	0.671	0.329
C91.8 Mature B-cell leukaemia Burkitt-type	0.326	0.673	0.001
C91.7 Other lymphoid leukaemia	0.326	0.673	0.001
C91.6 Prolymphocytic leukaemia of T-cell type	0.326	0.673	0.001
C91.3 Prolymphocytic leukaemia	0.326	0.673	0.001
C91.2 Subacute lymphocytic leukaemia	0.326	0.673	0.001
E12.9 Without complications	0.000	0.674	0.326
E12.8 With unspecified complications	0.000	0.674	0.326
E12.7 With multiple complications	0.000	0.674	0.326
E12.6 With other specified complications	0.000	0.674	0.326
E12.5 With peripheral circulatory complications	0.000	0.674	0.326
E12.4 With neurological complications	0.000	0.674	0.326
E12.3 With ophthalmic complications	0.000	0.674	0.326
E12.2 With renal complications	0.000	0.674	0.326
E12.1 With ketoacidosis	0.000	0.674	0.326
E12.0 With coma	0.000	0.674	0.326
J45 Asthma	0.000	0.675	0.325
E34 Other endocrine disorders	0.000	0.677	0.323
D80.2 Selective deficiency of immunoglobulin A [IgA]	0.000	0.678	0.321
E27.8 Other specified disorders of adrenal gland	0.000	0.679	0.321
M45.X0 Ankylosing spondylitis (Multiple sites in spine)	0.321	0.679	0.000
D56 Thalassaemia	0.000	0.680	0.319
C75 Malignant neoplasm of other endocrine glands and related structures	0.318	0.682	0.000
C06 Malignant neoplasm of other and unspecified parts of mouth	0.318	0.682	0.000
M07.38 Other psoriatic arthropathies (Other)	0.317	0.682	0.000
M07.35 Other psoriatic arthropathies (Pelvic region and thigh)	0.317	0.682	0.000
M07.34 Other psoriatic arthropathies (Hand)	0.317	0.682	0.000
M07.33 Other psoriatic arthropathies (Forearm)	0.317	0.682	0.000
M07.32 Other psoriatic arthropathies (Upper arm)	0.317	0.682	0.000
M07.31 Other psoriatic arthropathies (Shoulder region)	0.317	0.682	0.000
M07.30 Other psoriatic arthropathies (Multiple sites)	0.317	0.683	0.000
C40-C41 Malignant neoplasms of bone and articular cartilage	0.315	0.685	0.000
D89.9 Disorder involving the immune mechanism, unspecified	0.000	0.686	0.314
D89.8 Other specified disorders involving the immune mechanism, not elsewhere classified	0.000	0.686	0.314
D89.3 Immune reconstitution syndrome	0.000	0.686	0.314
D89.0 Polyclonal hypergammaglobulinaemia	0.000	0.686	0.314
M06.49 Inflammatory polyarthropathy (Site unspecified)	0.313	0.687	0.000
C43.6 Malignant melanoma of upper limb, including shoulder	0.313	0.687	0.000
E21.0 Primary hyperparathyroidism	0.000	0.688	0.312
C02.1 Border of tongue	0.312	0.688	0.000
E22.1 Hyperprolactinaemia	0.000	0.689	0.311
C97-C97 Malignant neoplasms of independent (primary) multiple sites	0.310	0.690	0.000
Chapter XIII Diseases of the musculoskeletal system and connective tissue	0.310	0.690	0.000
M06.94 Rheumatoid arthritis, unspecified (Hand)	0.310	0.690	0.000
C05 Malignant neoplasm of palate	0.307	0.693	0.000
C92.9 Myeloid leukaemia, unspecified	0.306	0.693	0.000
C92.8 Acute myeloid leukaemia with multilineage dysplasia	0.306	0.693	0.000
C92.7 Other myeloid leukaemia	0.306	0.693	0.000
C92.6 Acute myeloid leukaemia with 11q23-abnormality	0.306	0.693	0.000
C92.5 Acute myelomonocytic leukaemia	0.306	0.693	0.000
C92.4 Acute promyelocytic leukaemia	0.306	0.693	0.000
C92.3 Myeloid sarcoma	0.306	0.693	0.000
C92.2 Subacute myeloid leukaemia	0.306	0.693	0.000
M11.9 Crystal arthropathy, unspecified	0.306	0.694	0.000
E14.9 Without complications	0.000	0.694	0.306
D59.8 Other acquired haemolytic anaemias	0.000	0.694	0.305
D59.6 Haemoglobinuria due to haemolysis from other external causes	0.000	0.694	0.305
D59.5 Paroxysmal nocturnal haemoglobinuria [Marchiafava-Micheli]	0.000	0.694	0.305
D59.4 Other nonautoimmune haemolytic anaemias	0.000	0.694	0.305
D59.3 Haemolytic-uraemic syndrome	0.000	0.694	0.305
D59.2 Drug-induced nonautoimmune haemolytic anaemia	0.000	0.694	0.305
D59.0 Drug-induced autoimmune haemolytic anaemia	0.000	0.694	0.305
C69-C72 Malignant neoplasms of eye, brain and other parts of central nervous system	0.305	0.695	0.000
E24.9 Cushing's syndrome, unspecified	0.000	0.695	0.305
E14.3 With ophthalmic complications	0.000	0.696	0.304
E22.9 Hyperfunction of pituitary gland, unspecified	0.000	0.696	0.304
E22.8 Other hyperfunction of pituitary gland	0.000	0.696	0.304
D58 Other hereditary haemolytic anaemias	0.000	0.696	0.304
D59.9 Acquired haemolytic anaemia, unspecified	0.000	0.697	0.303
E22.0 Acromegaly and pituitary gigantism	0.000	0.697	0.303
C43.4 Malignant melanoma of scalp and neck	0.299	0.701	0.000
C81.9 Hodgkin's disease, unspecified	0.297	0.702	0.000
E14.8 With unspecified complications	0.000	0.707	0.293
E14.7 With multiple complications	0.000	0.707	0.293
E14.2 Withrenal complications	0.000	0.707	0.293
E14.1 With ketoacidosis	0.000	0.707	0.293
E14.0 With coma	0.000	0.707	0.293
E29 Testicular dysfunction	0.000	0.708	0.292
E65-E68 Obesity and other hyperalimentation	0.000	0.708	0.291
E21.1 Secondary hyperparathyroidism, not elsewhere classified	0.000	0.710	0.290
C03 Malignant neoplasm of gum	0.289	0.711	0.000
M45.X8 Ankylosing spondylitis (Sacral and sacrococcygeal region)	0.289	0.711	0.000
M45.X7 Ankylosing spondylitis (Lumbosacral region)	0.289	0.711	0.000
M45.X6 Ankylosing spondylitis (Lumbar region)	0.289	0.711	0.000
M45.X5 Ankylosing spondylitis (Thoracolumbar region)	0.289	0.711	0.000
M45.X4 Ankylosing spondylitis (Thoracic region)	0.289	0.711	0.000
M45.X3 Ankylosing spondylitis (Cervicothoracic region)	0.289	0.711	0.000
M45.X1 Ankylosing spondylitis (Occipito-atlanto-axial region)	0.289	0.711	0.000
Z93 Artificial opening status	0.288	0.712	0.000
C10 Malignant neoplasm of oropharynx	0.288	0.712	0.000
E14.6 With other specified complications	0.000	0.717	0.283
C00 Malignant neoplasm of lip	0.281	0.718	0.000
M08.9 Juvenile arthritis, unspecified	0.281	0.719	0.000
M08.8 Other juvenile arthritis	0.281	0.719	0.000
M08.4 Pauciarticular juvenile arthritis	0.281	0.719	0.000
M08.3 Juvenile polyarthritis (seronegative)	0.281	0.719	0.000
M08.2 Juvenile arthritis with systemic onset	0.281	0.719	0.000
M08.1 Juvenile ankylosing spondylitis	0.281	0.719	0.000
M08.0 Juvenile rheumatoid arthritis	0.281	0.719	0.000
M09.8 Juvenile arthritis in other diseases classified elsewhere	0.281	0.719	0.000
M09.2 Juvenile arthritis in ulcerative colitis	0.281	0.719	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations